Medicon Hellas S.A. (ATH:MEDIC)

Greece · Delayed Price · Currency is EUR

2.840

-0.040 (-1.39%)

At close: Jul 17, 2026

24.56% (1Y)

Market Cap	12.55M +24.6%
Revenue (ttm)	17.95M -0.9%
Net Income	1.73M +26.8%
EPS	0.39 +26.8%
Shares Out	4.42M
PE Ratio	7.25
Forward PE	n/a
Dividend	0.13 (4.58%)
Ex-Dividend Date	Jul 13, 2026

Volume	414
Open	2.860
Previous Close	2.880
Day's Range	2.680 - 2.880
52-Week Range	2.250 - 3.110
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, contro... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1988

Employees 148

Stock Exchange Athens Stock Exchange

Ticker Symbol MEDIC

Full Company Profile

Financial Performance

In 2025, Medicon Hellas's revenue was 17.95 million, a decrease of -0.94% compared to the previous year's 18.12 million. Earnings were 1.73 million, an increase of 26.81%.

Financial Statements